Eugonia
16
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
44%
7 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Comparison of 2 Different Flow Rates During Oocyte Retrieval
Role: lead
Value of Follicular Flushing. Randomised Controlled Trial
Role: lead
2D Versus SonoAVC Scanning in High Responders
Role: lead
Follicular Flushing Versus Direct Aspiration
Role: lead
Effect of Follicle Flushing on Oocyte Fertilization Rate
Role: lead
Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders
Role: lead
Corifollitropin Alfa Versus Follitropin Beta in High Responders
Role: lead
Embryo Development Using Two Commercial Single-step Media
Role: lead
Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
Role: lead
Single-step Versus Sequential Media in Preimplantation Embryo Development and Pregnancy Rates
Role: lead
Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology
Role: lead
Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH
Role: lead
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
Role: lead
Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs
Role: lead
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
Role: lead
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients
Role: lead
All 16 trials loaded